DEPOMED INC | 4,433 Euro | +0,067 +1,53 % | |
| WKN: 911061 ISIN: US2499081048 Ticker-Symbol: DPO | Frankfurt | 24.05.13 | 08:02 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ Biotech |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 20.05. | DEPOMED INC - 8-K, Current Report | 1 | SEC Filings | |
| 16.05. | Depomed To Present At UBS Global Healthcare Conference | 39 | PR Newswire | |
| NEWARK, Calif., May 16, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the UBS Global Healthcare Conference at the Sheraton New York Hotel in New York... Mehr lesen zu: Depomed To Present At UBS Global Healthcare Conference | ||||
| 13.05. | Depomed Makes a Move: Up 5.7% | 2 | SmarTrend | |
| 09.05. | Review Of Depomed First Quarter 2013 Results | 5 | Seeking Alpha | |
| 09.05. | DepoMed Management Discusses Q1 2013 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 08.05. | DEPOMED INC - 8-K, Current Report | - | SEC Filings | |
| 08.05. | Depomed Reports First Quarter 2013 Financial Results | 23 | PR Newswire | |
| NEWARK, Calif., May 8, 2013 /PRNewswire/ --Depomed, Inc. (Nasdaq:DEPO) today reported financial results for the quarter ended March 31, 2013.
First Quarter 2013 Update
Total... Mehr lesen zu: Depomed Reports First Quarter 2013 Financial Results | ||||
| 03.05. | Possible Bullish Inside Day Candle Pattern Detected for Depomed | 1 | SmarTrend | |
| 01.05. | Depomed To Report First Quarter Fiscal Year 2013 Financial Results On Wednesday, May 8, 2013 | 24 | PR Newswire | |
| NEWARK, Calif., May 1, 2013 /PRNewswire/ --Depomed, Inc. (NASDAQ:DEPO) today announced that it will release first quarter fiscal year 2013 financial results after the market closes onWednesday, May... Mehr lesen zu: Depomed To Report First Quarter Fiscal Year 2013 Financial Results On Wednesday, May 8, 2013 | ||||
| 18.04. | Depomed sues rival Endo Pharmaceuticals over patents | 2 | bizjournals | |
| 17.04. | Depomed (DEPO) Files Complaint vs. Endo (ENDP) Over Patent Infringement | - | StreetInsider.com | |
| 17.04. | DEPOMED INC - 8-K, Other Events | 1 | SEC Filings | |
| 01.04. | Stock Investors Sell Off Shares of Depomed, Down 3.7% | 2 | SmarTrend | |
| 26.03. | Depomed has the Lowest Forward Earnings Yield in the Pharmaceuticals Industry | - | SmarTrend | |
| 13.03. | Depomed To Present At Roth Capital Partners 25th Annual Growth Stock Conference | 43 | PR Newswire | |
| NEWARK, Calif., March 13, 2013 /PRNewswire/ --Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Roth Capital Partners 25th Annual Growth Stock Conference at the Ritz-Carlton... Mehr lesen zu: Depomed To Present At Roth Capital Partners 25th Annual Growth Stock Conference | ||||
| 11.03. | Depomed Earnings Review: 19 Days after Announcement Shares Down 12.4% | - | SmarTrend | |
| 07.03. | Why Depomed Isn't Worth the Risk | 2 | Motley Fool | |
| 05.03. | FDA Panel Kills Sefelsa, Creates Buying Opportunity In Depomed Stock | 1 | Seeking Alpha | |
| 04.03. | Why DepoMed Shares Crashed | - | Motley Fool | |
| 04.03. | Possible Trend Reversal, Depomed Down on Heavy Volume | - | SmarTrend | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| CELL THERAPEUTICS | 0,944 | -4,26 % | Possible Bearish Inside Day Candle Pattern Detected for Cell Therapeutics |
| CELLDEX THERAPEUTICS | 9,367 | -2,84 % | Celldex Therapeutics Bullish Moving Average Crossover Alert |
| KERYX BIOPHARMACEUTICALS | 6,122 | +0,43 % | Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE) |
| CEL-SCI | 0,175 | -2,23 % | CEL-SCI Corporation To Present At The Second Annual Marcum LLP MicroCap Conference |
| AETERNA ZENTARIS | 1,513 | -1,75 % | Aeterna Zentaris: Posters to be Presented on Phase 1 and Phase 2 Trials with AEZS-108 in Prostate and Breast Cancer at Upcoming ASCO Meeting |
